HRP20080254A2 - Spojevi indolona koje se koriste za tretiranje kognitivnih oštećenja - Google Patents
Spojevi indolona koje se koriste za tretiranje kognitivnih oštećenjaInfo
- Publication number
- HRP20080254A2 HRP20080254A2 HR20080254A HRP20080254A HRP20080254A2 HR P20080254 A2 HRP20080254 A2 HR P20080254A2 HR 20080254 A HR20080254 A HR 20080254A HR P20080254 A HRP20080254 A HR P20080254A HR P20080254 A2 HRP20080254 A2 HR P20080254A2
- Authority
- HR
- Croatia
- Prior art keywords
- cognitive impairment
- compounds useful
- treat cognitive
- indoline compounds
- subject
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 5
- 208000028698 Cognitive impairment Diseases 0.000 title abstract 3
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title 1
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indolone Natural products C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 abstract 1
- -1 indolone compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Ovaj se izum odnosi na postupak tretiranja osobe s kognitivnim oštećenjima ili kongnitivnim poremećajem koji se sastoji od davanja osobi određene količine indolona koja efektivno djeluje u tretmanu kognitivnih oštećenja ili poremećaja kod te osobe.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74885105P | 2005-12-09 | 2005-12-09 | |
PCT/US2006/046826 WO2007070362A1 (en) | 2005-12-09 | 2006-12-08 | Indolone compounds useful to treat cognitive impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080254A2 true HRP20080254A2 (hr) | 2008-09-30 |
Family
ID=37903540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20080254A HRP20080254A2 (hr) | 2005-12-09 | 2008-06-09 | Spojevi indolona koje se koriste za tretiranje kognitivnih oštećenja |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP1957067B1 (hr) |
JP (1) | JP5336194B2 (hr) |
KR (1) | KR20080077646A (hr) |
CN (1) | CN101378750B (hr) |
AT (1) | ATE480234T1 (hr) |
AU (1) | AU2006326665B2 (hr) |
BG (1) | BG110157A (hr) |
BR (1) | BRPI0620034A2 (hr) |
CA (1) | CA2633829A1 (hr) |
CZ (1) | CZ2008423A3 (hr) |
DE (1) | DE602006016849D1 (hr) |
EA (1) | EA200870027A1 (hr) |
ES (1) | ES2349675T3 (hr) |
HK (1) | HK1127736A1 (hr) |
HR (1) | HRP20080254A2 (hr) |
IL (1) | IL192022A0 (hr) |
IS (1) | IS8733A (hr) |
MX (1) | MX2008007377A (hr) |
NO (1) | NO20083042L (hr) |
PL (1) | PL386471A1 (hr) |
RS (1) | RS20080257A (hr) |
SK (1) | SK500262008A3 (hr) |
WO (1) | WO2007070362A1 (hr) |
ZA (1) | ZA200805285B (hr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011090022A1 (ja) | 2010-01-20 | 2011-07-28 | 三菱瓦斯化学株式会社 | シアン酸エステル化合物およびその硬化物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK69693D0 (da) * | 1993-06-14 | 1993-06-14 | Neurosearch As | Farven lilla |
US20030078271A1 (en) | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
AU2003259759A1 (en) * | 2002-08-07 | 2004-02-25 | Synaptic Pharmaceutical Corporation | Gal3 receptor antagonists for the treatment of affective disorders |
TW200410937A (en) * | 2002-08-07 | 2004-07-01 | Synaptic Pharma Corp | 3-imino-2-indolones for the treatment of depression and/or anxiety |
WO2004014307A2 (en) * | 2002-08-07 | 2004-02-19 | Synaptic Pharmaceutical Corporation | Gal3 antagonists for the treatment of neuropathic pain |
-
2006
- 2006-12-08 PL PL386471A patent/PL386471A1/pl not_active Application Discontinuation
- 2006-12-08 EP EP06845000A patent/EP1957067B1/en not_active Not-in-force
- 2006-12-08 CZ CZ20080423A patent/CZ2008423A3/cs unknown
- 2006-12-08 WO PCT/US2006/046826 patent/WO2007070362A1/en active Application Filing
- 2006-12-08 SK SK50026-2008A patent/SK500262008A3/sk unknown
- 2006-12-08 JP JP2008544527A patent/JP5336194B2/ja not_active Expired - Fee Related
- 2006-12-08 CN CN2006800523099A patent/CN101378750B/zh not_active Expired - Fee Related
- 2006-12-08 EA EA200870027A patent/EA200870027A1/ru unknown
- 2006-12-08 DE DE602006016849T patent/DE602006016849D1/de active Active
- 2006-12-08 BR BRPI0620034-6A patent/BRPI0620034A2/pt not_active IP Right Cessation
- 2006-12-08 ZA ZA200805285A patent/ZA200805285B/xx unknown
- 2006-12-08 EP EP10171823A patent/EP2241316A1/en not_active Withdrawn
- 2006-12-08 RS RSP-2008/0257A patent/RS20080257A/sr unknown
- 2006-12-08 KR KR1020087015512A patent/KR20080077646A/ko not_active Application Discontinuation
- 2006-12-08 ES ES06845000T patent/ES2349675T3/es active Active
- 2006-12-08 MX MX2008007377A patent/MX2008007377A/es active IP Right Grant
- 2006-12-08 AU AU2006326665A patent/AU2006326665B2/en not_active Ceased
- 2006-12-08 CA CA002633829A patent/CA2633829A1/en not_active Abandoned
- 2006-12-08 AT AT06845000T patent/ATE480234T1/de not_active IP Right Cessation
-
2008
- 2008-06-09 BG BG110157A patent/BG110157A/en unknown
- 2008-06-09 HR HR20080254A patent/HRP20080254A2/hr not_active Application Discontinuation
- 2008-06-10 IL IL192022A patent/IL192022A0/en unknown
- 2008-06-12 IS IS8733A patent/IS8733A/is unknown
- 2008-07-09 NO NO20083042A patent/NO20083042L/no not_active Application Discontinuation
-
2009
- 2009-07-24 HK HK09106841.9A patent/HK1127736A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1127736A1 (en) | 2009-10-02 |
JP2009518431A (ja) | 2009-05-07 |
JP5336194B2 (ja) | 2013-11-06 |
WO2007070362A1 (en) | 2007-06-21 |
CN101378750A (zh) | 2009-03-04 |
MX2008007377A (es) | 2008-10-29 |
ES2349675T3 (es) | 2011-01-10 |
ATE480234T1 (de) | 2010-09-15 |
RS20080257A (en) | 2009-05-06 |
IL192022A0 (en) | 2009-08-03 |
CZ2008423A3 (cs) | 2009-08-05 |
IS8733A (is) | 2008-06-20 |
CN101378750B (zh) | 2012-07-18 |
AU2006326665A1 (en) | 2007-06-21 |
PL386471A1 (pl) | 2009-04-14 |
BG110157A (en) | 2008-12-30 |
EA200870027A1 (ru) | 2009-12-30 |
SK500262008A3 (sk) | 2009-03-05 |
EP2241316A1 (en) | 2010-10-20 |
EP1957067B1 (en) | 2010-09-08 |
CA2633829A1 (en) | 2007-06-21 |
DE602006016849D1 (de) | 2010-10-21 |
ZA200805285B (en) | 2009-12-30 |
AU2006326665B2 (en) | 2012-11-15 |
KR20080077646A (ko) | 2008-08-25 |
EP1957067A1 (en) | 2008-08-20 |
NO20083042L (no) | 2008-09-08 |
BRPI0620034A2 (pt) | 2011-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2368550E (pt) | Modulador do receptor de androgénios para o tratamento de cancro da próstata e doenças associadas ao receptor de androgénios | |
MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
MX2007016469A (es) | Metodos de tratamiento utilizando ansamicinas de hidroquinona. | |
MA29785B1 (fr) | Agents permettant de prevenir et de traiter des troubles entrainant la modulation des recepteurs ryr | |
SE0202241D0 (sv) | Novel Compounds | |
WO2006105516A3 (en) | Compositions and methods for diagnosing and treating neuropsychiatric disorders | |
WO2007062999A3 (en) | 1,5-substituted indol-2-yl amide derivatives | |
WO2007047447A3 (en) | Diuretic-like compound analogs useful for regulation of central nervous system disorders | |
HK1086487A1 (en) | Alpha-aminoamide derivatives useful as antimigraine agents | |
TW200605871A (en) | Carboxamido opioid compounds | |
WO2008155533A3 (en) | Phenothiazine compounds for treating mild cognitive impairment | |
TW200642690A (en) | Composition for treating central nervous system disorders | |
MX2009005351A (es) | Compuestos utiles para tratar trastornos neurodegenerativos. | |
TN2010000155A1 (en) | Organic compounds | |
TW200744577A (en) | Method for treating osteoarthritis | |
TW200742580A (en) | Methods for treating nephrolithiasis | |
BR0309708A (pt) | Compostos como moduladores de receptor de opióde | |
HK1115528A1 (en) | Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases | |
HK1083767A1 (en) | Combined use of a fibrate and orlistat for the treatment of obesity | |
HRP20080254A2 (hr) | Spojevi indolona koje se koriste za tretiranje kognitivnih oštećenja | |
HU0201394D0 (hr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20081204 Year of fee payment: 3 |
|
AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
OBST | Application withdrawn |